Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulfate 1g/h vs 2g/h for Eclampsia Prevention
NCT02396030Phase 4Terminated
- Sponsor
- IMIP
- Start
- Mar 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of magnesium sulfate in eclampsia, sponsored by IMIP. Started Mar 2015; status: terminated.
02
Drugs
magnesium sulfate
03
Conditions
eclampsia
Beyond the preview
Go deeper on NCT02396030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02396030.